In conclusion, our results show CR maintains immune responses against tumors in aged mice following the stimulation of OX40, a likely target for tumor immunotherapy, and suggest the aged host environment is a critical contributor to immune deficiency during aging. This evidence concerns the gene TNFRSF4 and neoplasm.